Witnessing the stock’s movement on the chart, on November 23, 2022, Zomedica Corp. (AMEX: ZOM) had a quiet start as it plunged -0.49% to $0.20. During the day, the stock rose to $0.21 and sunk to $0.20 before settling in for the price of $0.20 at the close. Taking a more long-term approach, ZOM posted a 52-week range of $0.17-$0.50.
Do You Own These 7 Inflation-Survival Stocks?
Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.
Click here to get your free copy of the report
Meanwhile, its Annual Earning per share during the time was 23.10%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 58.60%. This publicly-traded company’s shares outstanding now amounts to $979.95 million, simultaneously with a float of $965.42 million. The organization now has a market capitalization sitting at $198.62 million. At the time of writing, stock’s 50-day Moving Average stood at $0.2197, while the 200-day Moving Average is $0.2652.
It is quite necessary to find out the efficiency of the corporate organization, which has 47 number of employees on its payroll. For the Profitability, stocks gross margin was +46.32, operating margin was -517.14 and Pretax Margin of -501.22.
Zomedica Corp. (ZOM) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Drug Manufacturers – Specialty & Generic industry. Zomedica Corp.’s current insider ownership accounts for 1.48%, in contrast to 9.70% institutional ownership.
Zomedica Corp. (ZOM) Earnings and Revenue Records
As on 12/30/2020, Multinational firm has announced its last quarter scores, in which it reported -$0.01 earnings per share (EPS) for the period falling under the consensus outlook (set at $0) by -$0.01. This company achieved a net margin of -444.78 while generating a return on equity of -11.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
Zomedica Corp.’s EPS increase for this current 12-month fiscal period is 58.60%.
Zomedica Corp. (AMEX: ZOM) Trading Performance Indicators
Let’s observe the current performance indicators for Zomedica Corp. (ZOM). It’s Quick Ratio in the last reported quarter now stands at 17.50. The Stock has managed to achieve an average true range (ATR) of 0.01. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 16.41.
In the same vein, ZOM’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.02.
Technical Analysis of Zomedica Corp. (ZOM)
Going through the that latest performance of [Zomedica Corp., ZOM]. Its last 5-days volume of 5.32 million was inferior to the volume of 15.88 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 7.03% While, its Average True Range was 0.0118.